Skip to main content
. 2023 Nov 21;13:1221352. doi: 10.3389/fonc.2023.1221352

Figure 2.

Figure 2

Swimmer plot showing the overall clinical course. PTX+Cmab, paclitaxel+cetuximab; PCE, paclitaxel+carboplatin+cetuximab. *nivolumab (n=3), 5-FU+carboplatin+cetuximab (n=1) and docetaxel (n=1). †One patient received surgery for oligoprogressive disease in a locoregional lesion.